HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yaming Wang Selected Research

Phosphorus-32

11/2021Evaluation of Long-Term Outcomes and Toxicity After Stereotactic Phosphorus-32-Based Intracavitary Brachytherapy in Patients With Cystic Craniopharyngioma.
6/2018Phosphorus-32 interstitial radiotherapy for recurrent craniopharyngioma: Expressions of vascular endothelial growth factor and its receptor-2 and imaging features of tumors are associated with tumor radiosensitivity.
4/2018Drug distribution and clinical safety in treating cystic craniopharyngiomas using intracavitary radiotherapy with phosphorus-32 colloid.
5/2015Interstitial radiotherapy using phosphorus-32 for giant posterior fossa cystic craniopharyngiomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yaming Wang Research Topics

Disease

9Neoplasms (Cancer)
11/2021 - 03/2010
8Virus Diseases (Viral Diseases)
12/2015 - 03/2006
5Lymphoma (Lymphomas)
01/2022 - 06/2014
5Craniopharyngioma (Craniopharyngiomas)
11/2021 - 02/2012
5Infections
10/2021 - 02/2007
4Alzheimer Disease (Alzheimer's Disease)
01/2018 - 03/2015
3Neurodegenerative Diseases (Neurodegenerative Disease)
06/2022 - 01/2018
3Inflammation (Inflammations)
10/2017 - 03/2009
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2008 - 05/2007
2Cysts
11/2021 - 05/2015
2Abscess
10/2021 - 05/2017
2AIDS-Related Complex (ARC)
12/2018 - 01/2018
1Cognitive Dysfunction
06/2022
1Atrophy
06/2022
1Tissue Adhesions
10/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
04/2021
1Brain Diseases (Brain Disorder)
01/2021
1Carbon Monoxide Poisoning (Poisoning, Carbon Monoxide)
01/2021
1Pancreatitis
07/2020
1Hypoxia (Hypoxemia)
01/2020
1Cerebrospinal Fluid Leak
04/2018
1Amyloid Plaque
01/2018
1Colorectal Neoplasms (Colorectal Cancer)
01/2018
1Synostosis
07/2017
1Brain Abscess (Abscess, Brain)
05/2017
1Bites and Stings (Sting)
03/2016
1Radius Fractures (Radius Fracture)
03/2016
1Poxviridae Infections
12/2015
1Demyelinating Diseases (Demyelinating Disease)
05/2015
1Meningioma (Meningiomas)
01/2015
1Urinary Bladder Neoplasms (Bladder Cancer)
08/2013

Drug/Important Bio-Agent (IBA)

5LipidsIBA
07/2020 - 03/2015
5Proteins (Proteins, Gene)FDA Link
06/2018 - 12/2002
4Phosphorus-32IBA
11/2021 - 05/2015
4AntigensIBA
06/2012 - 08/2006
3Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 06/2014
3Biological ProductsIBA
01/2020 - 01/2015
3Monoamine Oxidase (MAO)IBA
12/2018 - 07/2017
3CytokinesIBA
11/2014 - 10/2013
2Biomarkers (Surrogate Marker)IBA
06/2022 - 08/2013
2Radioisotopes (Radionuclides)IBA
11/2021 - 02/2012
2Colloids (Colloid)IBA
06/2018 - 04/2018
2MagnesiumIBA
01/2018 - 03/2016
2Amyloid (Amyloid Fibrils)IBA
01/2018 - 01/2016
2AlloysIBA
01/2018 - 03/2016
2Rituximab (Mabthera)FDA Link
07/2017 - 06/2014
2Cytarabine (Cytosar-U)FDA LinkGeneric
07/2017 - 06/2014
2Dexamethasone (Maxidex)FDA LinkGeneric
07/2017 - 06/2014
2LigandsIBA
04/2017 - 11/2011
2Messenger RNA (mRNA)IBA
01/2015 - 02/2012
2Antiviral Agents (Antivirals)IBA
10/2013 - 09/2010
2Interferon Type IIBA
06/2012 - 09/2010
2c-Mer Tyrosine KinaseIBA
03/2009 - 01/2008
1SolutionsIBA
11/2021
1AcidsIBA
10/2021
1titanium alloy (TiAl6V4)IBA
10/2021
1Carbon MonoxideIBA
01/2021
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
07/2020
1dachengqi decoctionIBA
07/2020
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
02/2020
1Interleukin-10 (Interleukin 10)IBA
02/2020
1HexokinaseIBA
01/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2020
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2020
1Oxidoreductases (Dehydrogenase)IBA
01/2020
1adipic acid (adipate)IBA
12/2019
1terephthalic acid (terephthalate)IBA
12/2019
1poly(lactide) (polylactic acid)IBA
12/2019
1ApatitesIBA
12/2018
1TitaniumIBA
12/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2018
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
06/2018
1Pharmaceutical PreparationsIBA
04/2018
1Immune Checkpoint InhibitorsIBA
01/2018
1ZincIBA
01/2018
1Peptides (Polypeptides)IBA
01/2018
1Apolipoproteins E (ApoE)IBA
01/2018
1CalciumIBA
01/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2017
1hydroxide ionIBA
07/2017
1Anti-Bacterial Agents (Antibiotics)IBA
05/2017
1InterferonsIBA
12/2015
1NK Cell Lectin-Like Receptor Subfamily CIBA
12/2015
1CuprizoneIBA
05/2015
1Cyclin D1IBA
01/2015
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
06/2014
1Sialic Acid Binding Immunoglobulin-like LectinsIBA
05/2014
1Cefazolin (Ancef)FDA LinkGeneric
10/2013
1ChitosanIBA
10/2013
1EnzymesIBA
08/2013
1Tumor Biomarkers (Tumor Markers)IBA
08/2013
1ImmunosorbentsIBA
08/2013

Therapy/Procedure

6Radiotherapy
01/2020 - 02/2012
4Brachytherapy
11/2021 - 02/2012
4Therapeutics
05/2017 - 01/2002
3Drug Therapy (Chemotherapy)
01/2022 - 07/2017
1Punctures
11/2021
1Operative Surgical Procedures
11/2021
1Injections
10/2021
1Combination Drug Therapy (Combination Chemotherapy)
07/2017